eMedicine Specialties > Pediatrics: General Medicine > Rheumatology

Transient Synovitis: Differential Diagnoses & Workup

Author: Christine C Whitelaw, MD, Clinical Instructor, Assistant Professor, Department of Pediatrics, University of Louisville School of Medicine
Coauthor(s): Kenneth N Schikler, MD, Director, Pediatric Rheumatology, Department of Pediatrics, Kosair Children's Hospital; Associate Professor, University of Louisville School of Medicine
Contributor Information and Disclosures

Updated: Jul 17, 2009

Differential Diagnoses

Arthritis, Septic
Juvenile Idiopathic Arthritis
Juvenile Rheumatoid Arthritis
Osteomyelitis

Other Problems to Be Considered

Avascular necrosis
Fracture
Gonococcal arthritis
Lyme arthritis3
Rheumatic arthralgias
Soft tissue injury
Tumor or malignancy

Workup

Laboratory Studies

The following studies may be indicated in transient synovitis (TS):

  • CBC count: The white blood cell (WBC) count may be slightly elevated.
  • Erythrocyte sedimentation rate (ESR)
    • The erythrocyte sedimentation rate (ESR) may be slightly elevated. One study found that the combination of an ESR greater than 20 mm/h and/or a temperature greater than 37.5°C identified 97% of individuals with septic hip.4
    • Another study by Kocher et al used 4 independent predictors of septic arthritis to distinguish it from transient synovitis and the need for further workup.5 They concluded that patients who were nonweightbearing and had history of fever, an ESR greater than 40 mm/h, and a WBC count greater than 12,000 cells/mm had a 99.6% high predicted probability of septic arthritis.
    • Luhmann et al applied these 4 criteria to their patient population and discovered a 59% predicted probability.6 However, when they applied the 3 criteria of history of fever, a serum WBC count of greater than 12,000 cells/mm, and a previous health-care visit, they found a predicted probability of 71% that the patient had septic arthritis.
  • C-reactive protein
    • C-reactive protein (CRP) level rises within 6 hours after the onset of septic arthritis of the hip and peaks at 2 days.7
    • A CRP >2 mg/dL (>20 mg/L) has been found to be an independent risk factor strongly associated with septic hip arthritis.8
    • Adding in the CRP as a predictive factor, Jung et al found that patients with 4 of 5 predictors (body temperature >37 º C, ESR >20 mm/h, CRP >1 mg/dL, WBC >11,000/mL, and an increased hip joint space of >2 mm) had a high probability of having septic arthritis and were candidates for further study by MRI or joint aspiration.9
  • Urinalysis and culture: Both of these tests should be normal.
  • Urine glycosaminoglycans: One study found a decreased level of urine glycosaminoglycans in patients who were diagnosed with Perthe disease, compared with those with transient synovitis and a control group.
  • Procalcitonin levels: These may be helpful in distinguishing between bacterial infections and inflammatory processes. Procalcitonin levels remain low during bouts of inflammatory disease but increase in septic arthritis and may be even more useful in distinguishing septic arthritis from osteomyelitis.10

Imaging Studies

  • Anteroposterior and lateral radiography of the pelvis
    • Radiographs exclude bony lesions (eg, occult fracture, osteoid osteoma) unless the child had onset of symptoms within 3 days, has no fever, appears well, and has only mildly restricted abduction without guarding against movement in other planes.
    • Plain films may be normal for months after onset of symptoms.
    • Medial joint space may be slightly wider in the affected hip (see Media file 1).

      Widening of the joint space. Note that the space ...

      Widening of the joint space. Note that the space is wider on the left side. Discrepancies greater than 1 mm indicate the presence of fluid.

      Widening of the joint space. Note that the space ...

      Widening of the joint space. Note that the space is wider on the left side. Discrepancies greater than 1 mm indicate the presence of fluid.

    • If excess fluid is present or the patient has early Legg-Calvé-Perthes (LCP) disease, plain radiography may reveal an increase in the teardrop distance (ie, distance between the medial acetabulum and ossified part of the femoral head). Compared with the other side, this distance should be the same or within 1 mm.
    • One half to two thirds of patients with transient synovitis may have an accentuated pericapsular shadow.
    • In one study, as many as 58% of patients with transient synovitis had the Waldenström sign (ie, lateral displacement of the femoral epiphyses with surface flattening).
    • Other studies have reported a positive obturator sign in established incidents of transient synovitis. This is a prominent shadow caused by the soft tissues that overlie the interpelvic aspect of the acetabulum.
    • Radiography may reveal diminution of the definition of soft tissue planes around the hip joint or slight demineralization of the bone of the proximal femur, particularly in the metaphyseal region.
  • Ultrasonography
    • Although extremely accurate for detecting an intracapsular effusion, ultrasonography does not assist in determining the cause and is used best to guide hip aspiration. An effusion is present if ultrasound demonstrates capsular distension greater than 2 mm.
    • Occasionally, the radiologist can differentiate between transient synovitis and early LCP on the basis of effusion rather than synovial membrane thickening.  However, ultrasonography cannot rule out osteomyelitis or soft tissue infection.
  • MRI
    • A study by Lee et al proposed that physicians may differentiate transient synovitis from septic arthritis by considering the results of an MRI.11 This study found that septic arthritis demonstrated signal intensity alterations in the bone marrow of the affected hip.
    • Yang et al confirmed this finding in a study on 49 patients with transient synovitis and 18 patients with septic arthritis.12 He demonstrated not only the statistically significant finding of signal intensity in the bone marrow, but also found signal intensity alterations and contrast enhancement of the soft tissue in patients with septic arthritis. 
    • Furthermore, the statistically significant findings in the patients with transient synovitis included contralateral (asymptomatic) joint effusions and the absence of signal intensities in the bone marrow. Both diseases showed ipsilateral effusions with synovial thickening and enhancement.

Other Tests

  • Bone scintigraphy
    • This test demonstrates mildly elevated uptake; however, bone scintigraphy may also reveal a transient decrease in uptake of technetium 99m phosphate.
    • Bone scintigraphy does not help the physician differentiate etiologies.

Procedures

  • Aspiration with ultrasonographic guidance
    • Perform this procedure in all individuals in whom ultrasonography has exhibited evidence of an effusion and any of the following predictive criteria are present:
      • Temperature greater than 99.5°F
      • ESR greater than or equal to 20 mm/h
      • Severe hip pain and spasm with movement
    • The aspirate should assist the physician in differentiating transient synovitis from septic arthritis. The physician can confirm 30-50% of septic arthritis incidents with Gram stain. In individuals with septic arthritis, the WBC count varies (25,000-250,000/mcL); however, in these individuals, the WBC count consistently demonstrates 90% polymorphonuclear cells. Also, in persons with septic arthritis, the glucose is often less than 40 mg/dL or is markedly different from the serum glucose.
    • In one study, 36 children with an effusion underwent aspiration with ultrasonographic guidance. The Gram stain identified 1 child with an acute infection. The 35 children with a negative Gram stain were sent home with no further complications.
    • In another study published by Skinner et al, 25 children with a clinical diagnosis of transient synovitis were observed.13 They all had a joint effusion by ultrasound, but no aspiration was performed. The mean age of the patient population was 6 years, the average size of the effusions was 9 mm, and the distribution between the sides affected was equal. They found that by 2 weeks postdiagnosis, all patients were pain and limp free. The effusions, although still present in some, were decreasing in size. They concluded that transient synovitis is benign and can be treated with supportive therapy.

More on Transient Synovitis

Overview: Transient Synovitis
Differential Diagnoses & Workup: Transient Synovitis
Treatment & Medication: Transient Synovitis
Follow-up: Transient Synovitis
Multimedia: Transient Synovitis
References

References

  1. [Guideline] American College of Radiology, Expert Panel on Musculoskeletal Imaging. Chronic hip pain. ACR Appropriateness Criteria. 2003;[Full Text].

  2. [Guideline] Fordham L, Gunderman R, Blatt ER, et al. Limping child--ages 0-5 years. ACR Appropriateness Criteria. 2007;[Full Text].

  3. Saulsbury, Frank T. MD. Lyme Arthritis presenting as Transient Synovitis of the Hip. Clinical pediatrics. October 2008;47:8333-835. [Medline].

  4. Del Beccaro MA, Champoux AN, Bockers T, Mendelman PM. Septic arthritis versus transient synovitis of the hip: the value of screening laboratory tests. Ann Emerg Med. Dec 1992;21(12):1418-22. [Medline].

  5. Kocher MS, Mandiga R, Zurakowski D, et al. Validation of a clinical prediction rule for the differentiation between septic arthritis and transient synovitis of the hip in children. J Bone Joint Surg Am. Aug 2004;86-A(8):1629-35. [Medline].

  6. Luhmann SJ, Jones A, Schootman M, et al. Differentiation between septic arthritis and transient synovitis of the hip in children with clinical prediction algorithms. J Bone Joint Surg Am. May 2004;86-A(5):956-62. [Medline].

  7. Kallio MJ, Unkila-Kallio L, Aalto K, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J. Apr 1997;16(4):411-3. [Medline].

  8. Caird MS, Flynn JM, Leung YL, et al. Factors distinguishing septic arthritis from transient synovitis of the hip in children: a prospective study. The Journal of Bone and Joint Surgery. June 2006;88-B:1251-1257. [Medline].

  9. Jung ST, Rowe SM, Moon ES, et al. Significance of Laboratory and Radiologic Findings for Differentiating between Septic Arthritis and Transient Synovitis of the Hip. Journal of Pediatric Orthopedics. June 2003;23:368-372. [Medline].

  10. Butbul-Aviel Y, Koren A, Halevy R, et al. Procalcitonin as a Diagnostic Aid in Osteomyelitis and Septic Arthritis. Pediatric Emergency Care. December 2005;21:828-832. [Medline].

  11. Lee SK, Suh KJ, Kim YW, et al. Septic arthritis versus transient synovitis at MR imaging: preliminary assessment with signal intensity alterations in bone marrow. Radiology. May 1999;211(2):459-65. [Medline].

  12. Yang WJ, Im SA, Lim GY, et al. MR imaging of transient synovitis: differentiation from septic arthritis. Pediatr Radiol. Nov 2006;36(11):1154-8. [Medline].

  13. Skinner J, Glancy S, Beattie TF, Hendry GM. Transient Synovitis: is there a need to aspirate hip joint effusions?. European Journal of Emergency Medicine. 2002;9:15-8. [Medline].

  14. Kermond S, Fink M, Graham K, Carlin JB, Barnett P. A randomized clinical trial: should the child with transient synovitis of the hip be treated with nonsteroidal anti-inflammatory drugs?. Ann Emerg Med. Sep 2002;40(3):294-9. [Medline].

  15. Caird MS, Flynn JM, Leung YL, et al. Factors distinguishing septic arthritis from transient synovitis of the hip in children: a prospective study. The Journal of Bone and Joint Surgery. June 2006;88-B:1251-1257. [Medline].

  16. Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology. 3rd ed. 1995:505.

  17. Chung SM. Diseases of the developing hip joint. Pediatr Clin North Am. Dec 1986;33(6):1457-73. [Medline].

  18. Connolly LP, Connolly SA. Skeletal scintigraphy in the multimodality assessment of young children with acute skeletal symptoms. Clin Nucl Med. Sep 2003;28(9):746-54. [Medline].

  19. Eggl H, Drekonja T, Kaiser B, Dorn U. Ultrasonography in the diagnosis of transient synovitis of the hip and Legg-Calve-Perthes disease. J Pediatr Orthop B. Jul 1999;8(3):177-80. [Medline].

  20. Fink PC, Dufort JE, Smith-Wright D. Orthopedic disorders. In: Pediatric Emergency Medicine. 1996:937.

  21. Hart JJ. Transient synovitis of the hip in children. Am Fam Physician. Oct 1996;54(5):1587-91, 1595-6. [Medline].

  22. Haueisen DC, Weiner DS, Weiner SD. The characterization of "transient synovitis of the hip" in children. J Pediatr Orthop. Jan-Feb 1986;6(1):11-7. [Medline].

  23. Keenan GF. Transient synovitis. In: The Five Minute Pediatric Consult. 1997:736.

  24. Kermond S, Fink M, Graham K. A Randomized Clinical Trial: Should the Child with Transient Synovitis of the Hip be Treated with Nonsteroidal Anti-inflammatory Drugs?. Annals of Emergency Medicine. 2002;40:294-9. [Medline].

  25. Koop S, Quanbeck D. Three common causes of childhood hip pain. Pediatr Clin North Am. Oct 1996;43(5):1053-66. [Medline].

  26. Robben SG, Lequin MH, Diepstraten AF, et al. Anterior joint capsule of the normal hip and in children with transient synovitis: US study with anatomic and histologic correlation. Radiology. Feb 1999;210(2):499-507. [Medline].

  27. Simon RR, Koenigsknecht SJ. Hip, pelvis, and thigh. In: Emergency Orthopedics: The Extremities. 1995:421.

  28. Snider RK. Transient synovitis of the hip. In: Essentials of Musculoskeletal Care. 1998:667-8.

  29. Wan JY, Soo AI, Gye-yeon L, et al. MR imaging of transient synovitis: differentiation from septic arthritis. Pediatric Radiology. November 2006;36:1154-1158. [Medline].

  30. Wingstrand H. Transient synovitis of the hip in the child. Acta Orthop Scand Suppl. 1986;219:1-61. [Medline].

Further Reading

Keywords

transient synovitis, TS, acute transitory epiphysitis, coxitis fugax, coxitis serosa su simplex, epiphysitis irritable hip, observation hip, phantom hip, toxic synovitis, transitory coxitis, transitory hip arthritis, hip pain, osteoarthritis, upper respiratory tract infection, bronchitis, otitis media, log roll, treatment, diagnosis

Contributor Information and Disclosures

Author

Christine C Whitelaw, MD, Clinical Instructor, Assistant Professor, Department of Pediatrics, University of Louisville School of Medicine
Christine C Whitelaw, MD is a member of the following medical societies: American Academy of Pediatrics and Kentucky Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Kenneth N Schikler, MD, Director, Pediatric Rheumatology, Department of Pediatrics, Kosair Children's Hospital; Associate Professor, University of Louisville School of Medicine
Kenneth N Schikler, MD is a member of the following medical societies: Society for Adolescent Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Thomas JA Lehman, MD, FAAP, FACR, Clinical Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Weill-Cornell University; Chief, Hospital for Special Surgery
Thomas JA Lehman, MD, FAAP, FACR is a member of the following medical societies: PM American Allergy Society
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Lawrence K Jung, MD, Chief, Division of Pediatric Rheumatology, Children's National Medical Center
Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, and New York Academy of Sciences
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.